ArticleTrials2024

UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tract.

Kevin Stritt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.